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 Cost-eﬀ ectiveness and classiﬁ cation
This week the global health cynosure has been the World 
Health Assembly (WHA) in Geneva. On the agenda we’ve 
seen action plans galore: from tuberculosis control to 
disability to neonatal health. There have been follow-up 
reports on vaccination, non-communicable diseases, and 
nutrition. But one thing that hasn’t so far made it onto 
a WHA agenda is surgery. Conservative estimates dating 
back to 2006 put the global burden of surgically treatable 
disorders at 11%, and many such conditions—eg, road-
traﬃ  c injuries and cancer—are rising. Why the neglect?
WHO established the Global Initiative for Emergency and 
Essential Surgical Care in 2005 with the aim of engendering 
collaboration between “health professionals, professional 
societies, academic institutions, non-governmental 
organisations, and health authorities interested in 
improving surgical care in LMICs”. The forum has met 
biennially since 2005, but strategic outputs have been 
diﬃ  cult to identify. Similarly, the 2008 World Health Report 
recognised surgery as an essential spoke in the health-
system wheel, with primary care as the hub. Yet calls made 
back in 2010 for a “World Health Assembly amendment 
conﬁrming the critical role of emergency and essential 
surgery within the health system” have still not borne fruit.
The Lancet’s forthcoming Commission on Global 
Surgery aims to push the agenda forward. One of its key 
aims is to identify barriers to universal access to safe, 
aﬀ ordable, high-quality surgical care, and to clarify the 
role of all stakeholders in attaining this goal. As well as 
the Commission report, which is due early next year, a 
number of research papers will come out of the project, 
and The Lancet Global Health publishes one such paper this 
month. 
Tiﬀ any Chao and colleagues explore one of the potential 
barriers to the adequate provision of surgical care in low-
income countries and to its visibility on the global health 
agenda—its supposed high cost. In their systematic 
review, Chao and colleagues assessed 26 previous studies 
of the cost-eﬀ ectiveness of a range of essential surgical 
procedures across 24 countries. Standardised cost-
eﬀ ectiveness ratios were calculated in 2012 US dollars 
per disability-adjusted life-year (DALY) averted, and 
median values were found to be $13·78 for adult male 
circumcision; $47·74 for cleft lip and palate repair; $82·32 
for general surgery; $108·74 for hydrocephalus repair; 
$136·00 for ophthalmic surgery (cataract, trichiasis, 
and trachoma); $315·12 for caesarean deliveries; and 
$381·15 for orthopaedic surgery. Rather than relying on 
these ﬁ gures in isolation, or applying WHO’s standard 
measures of what is “cost-eﬀ ective” (one-to-three times 
greater than a country’s gross domestic product [GDP] 
per head) and “very cost-eﬀ ective” (less than a country’s 
GDP per head), Chao and colleagues go a step further and 
compare these ratios against those for interventions with 
existing donor and government support—ie, vaccines of 
the Expanded Program on Immunization, bednets, BCG 
vaccinations, and HIV treatment. All the median values 
for the surgical procedures studied were well within the 
cost range of these accepted interventions, nicely showing 
that surgery is a valuable addition to the toolbox of global 
health policy and practice.
Maternal deaths have also been in the headlines over 
recent weeks, with WHO and the Institute for Health Metrics 
and Evaluation (IHME) both releasing new estimates for 
2013. While methods diﬀ ered, and it is instructive to have 
these alternative measurements, the number of women 
estimated to have died in 2013 during pregnancy or shortly 
after childbirth were remarkably similar: 289 000 according 
to WHO and 293 000 according to IHME. The ﬁ ndings on 
why mothers die, however, were not so consistent. WHO’s 
analysis of the causes of maternal death are published in 
The Lancet Global Health this month, and put indirect causes 
such as diabetes, malaria, HIV, and obesity on a par with 
haemorrhage as the major causes of maternal mortality 
(around 27% of deaths each), with hypertension (14%) and 
sepsis (11%) the next most important contributors. The 
IHME ﬁ ndings indicate that indirect causes only accounted 
for around 10% of deaths, with hypertension at 12% and 
sepsis 9%. Abortion and “other direct causes” accounted 
for the most deaths according to IHME (around 17% each), 
with haemorrhage at around 14%. The Lancet Global Health 
paper includes a useful panel that unpicks some of the 
common problems encountered when classifying cause 
of maternal death, which undoubtedly account for some 
of these diﬀ erences. The main policy recommendation, 
then, is for data collection to be improved. Any death in 
pregnancy is a tragedy and ought to be recorded with the 
utmost care.
Copyright © Mullan. Open Access article distributed under the terms of CC BY.
Zoë Mullan
Editor, The Lancet Global Health
For estimates of the global 




For the 2008 World Health 
Report see http://www.who.int/
whr/2008/whr08_en.pdf
For the call for a WHA 
amendment on surgery see 
World J Surg 2010 34: 386–90.
For the Lancet Commission on 
Global Surgery see http://www.
thelancet.com/commissions/
global-surgery
For the WHO estimates of 





For the IHME estimates of 
maternal mortality for 
1990–2013 see Lancet 2014; 
published online May 2. 
http://dx.doi.org/10.1016/
S0140-6736(14)60696-6
See Articles pages e323 and e334
